ADMA Biologics Inc (NAS:ADMA)

$ 17.67 0.26 (1.49%) Market Cap: 4.12 Bil Enterprise Value: 4.14 Bil PE Ratio: 62.18 PB Ratio: 17.75 GF Score: 68/100

Q3 2024 ADMA Biologics Inc Earnings Call Transcript
Nov 07, 2024

$19.72 (+0.25%)

Earnings
Q2 2024 ADMA Biologics Inc Earnings Call Transcript
Aug 08, 2024

$12.19 (+6.46%)

Earnings
Q4 2023 ADMA Biologics Inc Earnings Call Transcript
Feb 28, 2024

$5.38 (-2.54%)

Earnings
Q3 2023 ADMA Biologics Inc Earnings Call Transcript
Nov 08, 2023

$3.62 (-1.90%)

Earnings
Q2 2023 ADMA Biologics Inc Earnings Call Transcript
Aug 09, 2023

$4.06 (-1.93%)

Earnings
Q1 2023 ADMA Biologics Inc Earnings Call Transcript
May 10, 2023

$3.57 (+2.88%)

Earnings
Q4 2022 ADMA Biologics Inc Earnings Call Transcript
Mar 23, 2023

$3.11 (+3.32%)

Earnings
Q3 2022 ADMA Biologics Inc Earnings Call Transcript
Nov 09, 2022

$2.47 (-5.36%)

Earnings
Q2 2022 ADMA Biologics Inc Earnings Call Transcript
Aug 10, 2022

$2.12 (+4.43%)

Earnings
Q1 2022 ADMA Biologics Inc Earnings Call Transcript
May 11, 2022

$1.43 (-11.18%)

Earnings
Q4 2021 ADMA Biologics Inc Earnings Call Transcript
Mar 24, 2022

$1.5 (+2.74%)

Earnings
Q3 2021 ADMA Biologics Inc Earnings Call Transcript
Nov 10, 2021

$1.4 (-1.41%)

Earnings
ADMA Biologics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 30, 2021
ADMA Biologics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 09, 2021
Q2 2021 ADMA Biologics Inc Earnings Call Transcript
Aug 11, 2021

$1.53 (-0.65%)

Earnings
ADMA Biologics Inc Annual Shareholders Meeting Transcript
May 27, 2021
Q1 2021 ADMA Biologics Inc Earnings Call Transcript
May 12, 2021

$1.67 (-3.47%)

Earnings
Q4 2020 ADMA Biologics Inc Earnings Call Transcript
Mar 25, 2021

$2.05 (+3.54%)

Earnings
ADMA Biologics Inc at Jefferies Virtual Plasma Summit Transcript
Mar 11, 2021
Q3 2020 ADMA Biologics Inc Earnings Call Transcript
Nov 05, 2020

$2.11 (-1.40%)

Earnings
ADMA Biologics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 14, 2020
Q2 2020 ADMA Biologics Inc Earnings Call Transcript
Aug 05, 2020

$3.56 (+5.64%)

Earnings
Q1 2020 ADMA Biologics Inc Earnings Call Transcript
May 06, 2020

$3.2 (+0.95%)

Earnings
Q4 2019 ADMA Biologics Inc Earnings Call Transcript
Mar 12, 2020

$2.19 (-5.19%)

Earnings

Q4 2020 ADMA Biologics Inc Earnings Call Transcript

Mar 25, 2021 / 08:30PM GMT

Release Date Price: $2.05 (+3.54%)

Transcript 10-K8-K

Operator

Good afternoon, and welcome to the ADMA Biologics Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, March 25, 2021. (Operator Instructions) Please be advised that this call is being recorded at the company's request and will be available on the company's website approximately 2 hours following the end of the call. At this time, I would like to introduce Skyler Bloom, Director, Investor Relations and Corporate Strategy at ADMA Biologics. Please go ahead.

Skyler Bloom

ADMA Biologics, Inc. - Director of IR & Corporate Strategy

Welcome, everyone, and thank you for joining us this afternoon to discuss ADMA Biologics financial results for the fourth quarter and full year 2020. I'm joined today by Adam Grossman, President and Chief Executive Officer; and Brian Lenz, Executive Vice President and Chief Financial Officer. During today's call, Adam will provide some introductory comments and provide a corporate update and then Brian will provide an overview of the company's fourth quarter and year ended December 31, 2020 financial

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.